IL17A and inflammatory bowel disease: In parallel, intestinal inflammation in IBD patients is associated with an accumulation of IL-17+ ILC3s in the ileum and colon and an increased capacity of IL-23 to trigger the expression of IL-17A in gut-derived ILC3s (6, 52).